Zydus Lifesciences on Friday said its subsidiary Zydus Worldwide DMCC has received tentative approval from the US health regulator to market its generic version of Selexipag tablets, used to treat pulmonary arterial hypertension in adults...
.jpg)
The UK's state-funded National Health Service said that from Thursday it is rolling out the use of arthritis drug Baricitinib after it has proven to save lives when given to the most seriously ill COVID patients in hospital.
Novavax Inc said on Wednesday it had filed an application with Britain's drugs regulator for the authorization of its COVID-19 vaccine among adolescents aged 12 and older...
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached a distribution agreement with Premas Life Sciences Pvt. Ltd., India, a leading biotechnology distribution company. This partnership expands DNA Script’s...
Branded formulations manufacturer, Eris Lifesciences Ltd on Tuesday acquired a 100% stake in Mumbai-based Oaknet Healthcare Private Ltd for a total consideration of Rs 650 crore....
Pfizer has set up a global drug development centre at the IIT Madras Research Park in Chennai, India...
Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...
Alembic Pharmaceuticals Limited (Alembic) announced that its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from...
Rezolute, Inc., a clinical-stage biopharmaceutical company, announced positive results from its phase 2b RIZE study of RZ358 in patients with congenital hyperinsulinism (HI), which were unveiled in a late-breaking oral presentation at the Paediatric.
Aurobindo Pharma on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator to manufacture and market its generic version of Bortezomib for injection used to treat certain types....
, CDSCO.jpg)
